Antimalarial efficacy of a quantified extract of nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malariapart 1: A clinical phase IIA trial

Planta Medica

Volumn 78, Issue 3, 2012, Pages 211-218

  Mesia, Kahunu ^a   Tona, Lutete ^a   Mampunza, Ma Miezi ^a   Ntamabyaliro, Nsengi ^a   Muanda, Tsobo ^a   Muyembe, Tamfum ^a   Cimanga, Kanyanga ^a,b   Totté, Jozef ^b   Mets, Tony ^c   Pieters, Luc ^b   Vlietinck, Arnold J ^b  

^a UNIVERSITY OF KINSHASA   (Congo)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

herbal medicine; malaria; Nauclea pobeguinii; Plasmodium falciparum; Rubiaceae; strictosamide; traditional medicine

Indexed keywords

NAUCLEA POBEGUINII EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ANOREXIA; ANTIMALARIAL ACTIVITY; ARTICLE; BARK; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; INCREASED APPETITE; MALARIA FALCIPARUM; MALE; MEDICINAL PLANT; NAUCLEA POBEGUINII; NAUSEA; PARASITEMIA; PHASE 2 CLINICAL TRIAL; PLANT STEM; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTIMALARIALS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; RUBIACEAE; VINCA ALKALOIDS; YOUNG ADULT;

ANIMALIA; MUS; NAUCLEA; PLASMODIUM FALCIPARUM; RUBIACEAE;

EID: 84857233191     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1280359     Document Type: Article

References (30)

1. American Cancer Society. Clinical trials: What you need to know. Available at http://www.cancer.org/docroot/ETO Last accessed March 17, 2010
2. Dhooghe L, Mesia K, Kohtala E, Tona L, Pieters L, Vlietinck A J. Development and validation of an HPLC-method for the determination of alkaloids in the stem bark extract of Nauclea pobeguini i. Talanta 2008 15 462-468
3. Mesia K G., Cimanga K R., Dhooghe L, Cos P, Apers S, Totté J, Tona L G., Pieters L, Vlietinck A J., Maes L. Antimalarial activity and toxicity evaluation of a quantified Nauclea pobeguinii extract. J Ethnopharmacol 2010 131 10-16
4. Mesia K, Cimanga K, Tona L, Mampunza M M., Ntamabyaliro N, Muanda T, Muyembe T, Totté J, Pieters L, Vlietinck A. Assessment of the short-term safety and tolerability of a quantified 80% ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study. Planta Med 2011 77 111-116
5. US Department of Health and Human Services, Food and Drug Administration. Guidance for industry, investigators, and reviewers Exploratory IND studies. Geneva WHO 2006 (Available at http://www.fda.gov/downloads/Drugs/ Guidance%20ComplianceRegulatoryInformation/Guidances/ucm078933.pdf Last accessed March 17, 2010)
6. WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO/HTM/RBM/2003 Geneva WHO 2003 1-68
7. WHO. Guidelines for good clinical practice (GCP) for trials on pharmaceutical products. Adapted from The use of essential drugs, 8th list. WHO Technical Report Series, No. 850 Geneva WHO 1995
8. Karbwang J, Patou C. Standard operating procedures for clinical investigators. TDR/TDP/SOP/99.1.version 1.1 Geneva WHO 1999 (Available at http://whqlibdoc.who.int/hq/1999/TDR-TDP-SOP-99.1.pdf Last accessed May 10, 2010)
9. Radloff P D., Philipps J, Nkeyi M, Hutchinson D, Kremsner P G. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 1996 347 1511-1514 (Pubitemid 26162641)
10. Willcox M, Olanrewaju O. Guidelines for clinical studies on herbal antimalarials. In: Willcox M Bodeker G Rasoanaivo P eds. Traditional medicinal plants and malaria. Boca Raton, FL CRC Press 2004 321-332
11. Mueller M S., Runyambo N, Wagner I, Borrmann S, Dietz K, Heide L. Randomised controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans Royal Soc Trop Med Hyg 2004 98 318-321 (Pubitemid 38950411)
12. Garcia L S. Malaria and babesiosis. Diagnostic medical parasitology. 4th edn Washington DC ASM Press 2001 159-204
13. WHO. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Available at http://www.who.int/drugresistance/malaria/en/Assessment-malaria-96.pdf Last accessed 10 February 2011
14. Sowunmi A, Balogun S T., Gbotosho G O., Happi C T. Effects of amodiaquine, artesunate, and artesunateamodiaquine on Plasmodium falciparum malaria-associated anaemia in children. Acta Trop 2009 109 55-60
15. Vaidya A B., Vaidya R A. Initial human trials with an investigational new drug (Phase 1 and 2): planning and management. Postgrad Med J 1981 27 197-213
16. Willcox M L. A clinical trial of AM, a Ugandan herbal remedy for malaria. J Publ Health Med 1999 21 318-324 (Pubitemid 29446072)
17. Willcox M L., Graz B, Falquet J, Sidibé O, Forster M, Diallo D. Argemone mexicana decoction for the treatment of uncomplicated falciparum malaria. Trans Royal Soc Trop Med Hyg 2007 101 1190-1198 (Pubitemid 350028620)
18. Benoit-Vical F, Valentin A, Dab B, Dakuyo Z, Descamps L, Mallié M. N'Dribala (Cochlospermum planchonii) versus chloroquine for treatment of uncomplicated Plasmodium falciparum malaria. J Ethnopharmacol 2003 89 111-114 (Pubitemid 37163808)
19. Diallo D, Maga B, Diakité C, Willcox M. Malarial-5: Development of an antimalarial phytomedicine in Mali. In: Willcox M Bodeker G Rasoanaivo P eds. Traditional medicinal plants and malaria. Boca Raton, FL CRC Press 2004 117-130
20. White N J. The assessment of antimalarial drug efficacy. Trends Parasitol 2002 18 458-464
21. Bloland P B., Kazembe P N., Oloo A J., Himonga B, Barat L M., Ruebush T K. Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Trop Med Int Health 1998 3 543-552 (Pubitemid 28373863)
22. Guiguemdé R T., Gbary R A., Coulibaly S O., Ouedraogo J B. Comment réaliser et interpréter les résultats d'une épreuve de chimiorésistance de P. falciparum chez les sujets malades en zone tropicale. Cahiers Santé 1996 3 187-191 (Pubitemid 26230258)
23. Yeramian P, Meshnick S R., Krudsood S, Chalermrut K, Silachamroon U, Tangpukdee N, Allen J, Brun R, Kwiek J J., Tidwell R, Looareesuwan S. Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections. J Infect Dis 2005 192 319-322 (Pubitemid 40993402)
24. Tagbor H, Bruce J, Browne E, Randal A, Greenwood B, Chandramohan D. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine- pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial. Lancet 2006 368 1349-1356 (Pubitemid 44528748)
25. Osorio L, Gonzalez I, Olliaro P, Taylor W R. J. Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Malaria J 2007 6 25
26. Smith T, Hurt N, Teuscher T, Tanner M. Is fever a good sign for clinical malaria in surveys of endemic communities? Am J Trop Med Hyg 1995 52 306-310
27. Luxemburger C, Nosten F, Kyle D E., Kiricharoen L, Chongsuphajaisiddhi T, White N J. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in area of low transmission. Trans Royal Soc Trop Med Hyg 1998 92 45-49 (Pubitemid 28073728)
28. Missinou M A., Borrmann S, Schindler A, Issifou S, Adegnika A A., Matsiegui P B., Binder R, Lell B, Wiesner J, Baranek T, Jomaa H, Kremsner P G. Fosmidomycin for malaria. Lancet 2002 360 1941-1942 (Pubitemid 35472137)
29. Pieters L, Vlietinck A. Bioguided isolation of pharmacologically active plant components, still a valuable strategy for the finding of new lead compounds? J Ethnopharmacol 2005 100 57-60 (Pubitemid 41073522)
30. Xu Y J., Capistrano R, Dhooghe L, Foubert K, Maregesi S, Balde A, Apers S, Pieters L. Herbal medicines and infectious diseases: characterization by LC-SPE-NMR of some medicinal plant extracts used against malaria. Planta Med 2011 77 1139-1148